Prednisolone Co-Administered with Losartan Confers Renoprotection in Patients with IgA Nephropathy

BACKGROUND: Treatment options for progressive IgA nephropathy are limited. METHODS: We performed a small, randomized controlled trial to evaluate the effects of prednisolone (PSL, 30 mg/dL, gradually tapered to 5 mg/dL over two years) plus 50 mg/day of losartan (LST, an angiotensin II receptor block...

Descripción completa

Detalles Bibliográficos
Autores principales: Horita, Yoshio, Tadokoro, Masato, Taura, Kouichi, Ashida, Ryuichi, Hiu, Mayumi, Taguchi, Takashi, Furusu, Akira, Kohno, Shigeru
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409178/
https://www.ncbi.nlm.nih.gov/pubmed/17497466
http://dx.doi.org/10.1080/08860220701260511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409178/
https://www.ncbi.nlm.nih.gov/pubmed/17497466
http://dx.doi.org/10.1080/08860220701260511

Ejemplares similares